Recursion Pharmaceuticals, Inc. Dividend History (RXRX)
Recursion Pharmaceuticals, Inc. does not pay dividends currently 😔
They might in the future, check back soon!
About Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced machine learning techniques and high-throughput experiments to accelerate drug discovery and development. Founded in 2013 by Chris Gibson, who also serves as the CEO, Recursion aims to transform pharmacology by integrating technology and biology at an unprecedented scale. The company focuses on uncovering novel therapies for a wide range of diseases, particularly rare genetic disorders and complex diseases. By utilizing a distinctive approach combining data science, machine learning, and automation, Recursion seeks to predict, identify, and develop effective treatments faster than traditional methods. With a commitment to innovation, Recursion has seen significant growth and has attracted substantial investments to support its ambitious vision of redefining the future of medicine.
Apple Inc.
Microsoft Corporation
Johnson & Johnson
Procter & Gamble Co.
Coca-Cola Co.
PepsiCo, Inc.
Exxon Mobil Corporation
Verizon Communications Inc.
AT&T Inc.
Chevron Corporation
